Protalix BioTherapeutics
PLX
#8747
Rank
NZ$0.28 B
Marketcap
NZ$3.56
Share price
-0.94%
Change (1 day)
-10.00%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): NZ$0.02662

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is NZ$0.03470. In 2024 the company made an earnings per share (EPS) of NZ$0.06941 a decrease over its 2023 EPS that were of NZ$0.21.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.02662-61.64%
2024NZ$0.06941-66.67%
2023NZ$0.21-138.71%
2022NZ-$0.54-50%
2021NZ-$1.08181.82%
2020NZ-$0.38-82.11%
2019NZ-$2.13-31.67%
2018NZ-$3.12-72.31%
2017NZ-$11.28124.14%
2016NZ-$5.03-147.54%
2015NZ$10.58-290.63%
2014NZ-$5.556.67%
2013NZ-$5.21130.77%
2012NZ-$2.26-69.77%
2011NZ-$7.4619.44%
2010NZ-$6.25-12.2%
2009NZ-$7.1136.67%
2008NZ-$5.21-37.5%
2007NZ-$8.3350%
2006NZ-$5.553.23%
2005NZ-$5.38138.46%
2004NZ-$2.26-74%
2003NZ-$8.68-0%
2002NZ-$8.68-50%
2001NZ-$17.35233.33%
2000NZ-$5.21-84.21%
1999NZ-$32.97-24%
1998NZ-$43.38-600%
1997NZ$8.68-16.67%
1996NZ$10.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
NZ-$0.19-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$7.48 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.98 8,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.09 3,050.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel